Coagulant Therapeutics
OverviewSuggest Edit
Coagulant Therapeutics ( ㈜코애귤런트테라퓨틱스는 중증산후출혈) is a biotechnology company seeking to address acute bleeding. It develops a proprietary rFVIIa molecule, termed CT-001, for the safe pharmaceutical intervention for the treatment of acute bleeding.
| Type | Private | |
| Founded | 2017 | |
| HQ | San Francisco, CA, US | Map |
| Website | coagulanttherapeutics.com |
Locations
Latest Updates
| Cybersecurity rating | A | More |
Coagulant Therapeutics Office Locations
Coagulant Therapeutics has an office in San Francisco
San Francisco, CA, US (HQ)
455 Mission Bay Boulevard South, San Francisco
Coagulant Therapeutics Financials and Metrics
Summary Metrics
Founding Date | 2017 |
Coagulant Therapeutics Cybersecurity Score
Coagulant Therapeutics Online and Social Media Presence
Coagulant Therapeutics's Trends
Coagulant Therapeutics Frequently Asked Questions
When was Coagulant Therapeutics founded?
Coagulant Therapeutics was founded in 2017.
Who are Coagulant Therapeutics competitors?
Competitors of Coagulant Therapeutics include L2P Research, Paras Biopharmaceuticals and Planet Biotechnology.
Where is Coagulant Therapeutics headquarters?
Coagulant Therapeutics headquarters is located at 455 Mission Bay Boulevard South, San Francisco, San Francisco.
Where are Coagulant Therapeutics offices?
Coagulant Therapeutics has an office in San Francisco.
How many offices does Coagulant Therapeutics have?
Coagulant Therapeutics has 1 office.
Learn about Craft real-time company insights
Receive alerts for 300+ data fields across thousands of companies